FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793054258> ?p ?o ?g. }

• W2793054258 endingPage "14305" @default.
• W2793054258 startingPage "14296" @default.
• W2793054258 abstract "// Hironori Fukuda 1 , Toshio Takagi 1 , Tsunenori Kondo 2 , Satoru Shimizu 3 and Kazunari Tanabe 1 1 Department of Urology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan 2 Department of Urology, Tokyo Women’s Medical University Medical Center East, Arakawa-ku, Tokyo, Japan 3 Department of Medical Education, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan Correspondence to: Toshio Takagi, email: t.takagi1192@gmail.com Keywords: renal cell carcinoma; metastasis; cytoreductive nephrectomy; prognosis; inflammation-based prognostic score Received: July 26, 2017      Accepted: February 10, 2018      Epub: February 16, 2018      Published: March 06, 2018 ABSTRACT Inflammation-based prognostic scores are useful for predicting survival in various cancers. Here, we aimed to determine the most useful inflammation-based prognostic score for predicting survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. We retrospectively analyzed the data of 152 patients who underwent cytoreductive nephrectomy for metastatic renal cell carcinoma between 1986 and 2015. In the multivariate stepwise analysis, the combination of age, Memorial Sloan-Kettering Cancer Center score, histology, sarcomatoid change, clinical nodal stage, brain metastasis, and liver metastasis was a significant predictor for survival (Harrell's concordance index [c-index]: 0.638). The c-index of the combination improved with the addition of an inflammation-based prognostic score: C-reactive protein (c-index: 0.672), Glasgow prognostic score (c-index: 0.674), neutrophil-to-lymphocyte ratio (c-index: 0.685), lymphocyte-to-monocyte ratio (c-index: 0.670), platelet-to-lymphocyte ratio (c-index: 0.666), systemic inflammation response index (c-index: 0.652), and systemic immune-inflammation index (c-index: 0.678). The neutrophil-to-lymphocyte ratio provided the greatest improvement in the c-index. Additional multivariate analysis showed that the neutrophil-to-lymphocyte ratio was an independent prognostic factor for survival ( P < 0.0001). The neutrophil-to-lymphocyte ratio was the most useful inflammation-based prognostic score for predicting survival in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy." @default.
• W2793054258 created "2018-03-29" @default.
• W2793054258 creator A5002205066 @default.
• W2793054258 creator A5025231015 @default.
• W2793054258 creator A5068644980 @default.
• W2793054258 creator A5072292164 @default.
• W2793054258 creator A5073431810 @default.
• W2793054258 date "2018-02-16" @default.
• W2793054258 modified "2023-09-30" @default.
• W2793054258 title "Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy" @default.
• W2793054258 cites W1540590525 @default.
• W2793054258 cites W1841968883 @default.
• W2793054258 cites W1921663853 @default.
• W2793054258 cites W1965037168 @default.
• W2793054258 cites W1978274977 @default.
• W2793054258 cites W1982453726 @default.
• W2793054258 cites W1988902102 @default.
• W2793054258 cites W1994581907 @default.
• W2793054258 cites W1999966467 @default.
• W2793054258 cites W2000400906 @default.
• W2793054258 cites W2008733508 @default.
• W2793054258 cites W2009821632 @default.
• W2793054258 cites W2021256410 @default.
• W2793054258 cites W2040259869 @default.
• W2793054258 cites W2044702943 @default.
• W2793054258 cites W2051820020 @default.
• W2793054258 cites W2069979630 @default.
• W2793054258 cites W2071684942 @default.
• W2793054258 cites W2072478300 @default.
• W2793054258 cites W2078419070 @default.
• W2793054258 cites W2084139018 @default.
• W2793054258 cites W2105937199 @default.
• W2793054258 cites W2107934474 @default.
• W2793054258 cites W2116661424 @default.
• W2793054258 cites W2118278569 @default.
• W2793054258 cites W2118677643 @default.
• W2793054258 cites W2143782771 @default.
• W2793054258 cites W2147392387 @default.
• W2793054258 cites W2153867442 @default.
• W2793054258 cites W2156408558 @default.
• W2793054258 cites W2162424705 @default.
• W2793054258 cites W2169372773 @default.
• W2793054258 cites W2284518822 @default.
• W2793054258 cites W2335716140 @default.
• W2793054258 cites W2464839949 @default.
• W2793054258 cites W2470800392 @default.
• W2793054258 cites W2514084143 @default.
• W2793054258 cites W2570618306 @default.
• W2793054258 cites W2591004653 @default.
• W2793054258 cites W2601742986 @default.
• W2793054258 cites W2604665500 @default.
• W2793054258 cites W2604775892 @default.
• W2793054258 cites W2609548292 @default.
• W2793054258 doi "https://doi.org/10.18632/oncotarget.24507" @default.
• W2793054258 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5865670" @default.
• W2793054258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29581844" @default.
• W2793054258 hasPublicationYear "2018" @default.
• W2793054258 type Work @default.
• W2793054258 sameAs 2793054258 @default.
• W2793054258 citedByCount "37" @default.
• W2793054258 countsByYear W27930542582018 @default.
• W2793054258 countsByYear W27930542582019 @default.
• W2793054258 countsByYear W27930542582020 @default.
• W2793054258 countsByYear W27930542582021 @default.
• W2793054258 countsByYear W27930542582022 @default.
• W2793054258 countsByYear W27930542582023 @default.
• W2793054258 crossrefType "journal-article" @default.
• W2793054258 hasAuthorship W2793054258A5002205066 @default.
• W2793054258 hasAuthorship W2793054258A5025231015 @default.
• W2793054258 hasAuthorship W2793054258A5068644980 @default.
• W2793054258 hasAuthorship W2793054258A5072292164 @default.
• W2793054258 hasAuthorship W2793054258A5073431810 @default.
• W2793054258 hasBestOaLocation W27930542581 @default.
• W2793054258 hasConcept C121608353 @default.
• W2793054258 hasConcept C126322002 @default.
• W2793054258 hasConcept C143998085 @default.
• W2793054258 hasConcept C2777472916 @default.
• W2793054258 hasConcept C2779013556 @default.
• W2793054258 hasConcept C2780091579 @default.
• W2793054258 hasConcept C2780227381 @default.
• W2793054258 hasConcept C71924100 @default.
• W2793054258 hasConceptScore W2793054258C121608353 @default.
• W2793054258 hasConceptScore W2793054258C126322002 @default.
• W2793054258 hasConceptScore W2793054258C143998085 @default.
• W2793054258 hasConceptScore W2793054258C2777472916 @default.
• W2793054258 hasConceptScore W2793054258C2779013556 @default.
• W2793054258 hasConceptScore W2793054258C2780091579 @default.
• W2793054258 hasConceptScore W2793054258C2780227381 @default.
• W2793054258 hasConceptScore W2793054258C71924100 @default.
• W2793054258 hasIssue "18" @default.
• W2793054258 hasLocation W27930542581 @default.
• W2793054258 hasLocation W27930542582 @default.
• W2793054258 hasLocation W27930542583 @default.
• W2793054258 hasLocation W27930542584 @default.
• W2793054258 hasOpenAccess W2793054258 @default.
• W2793054258 hasPrimaryLocation W27930542581 @default.
• W2793054258 hasRelatedWork W1976968719 @default.
• W2793054258 hasRelatedWork W2045737731 @default.

• next